Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC

G.A. Simkens*, A.G. Wintjens, K.P. Rovers, S.W. Nienhuijs, I.H. de Hingh

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)5239-5249
Number of pages11
JournalCancer Management and Research
Volume13
DOIs
Publication statusPublished - 2021

Keywords

  • colorectal neoplasms
  • peritoneal metastases
  • cytoreductive surgery
  • hyperthermic intraperitoneal chemotherapy
  • prognosis
  • survival
  • HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY
  • DISEASE SEVERITY SCORE
  • COLON-CANCER
  • CURATIVE TREATMENT
  • LIVER METASTASES
  • KRAS MUTATION
  • PATHOLOGICAL RESPONSE
  • PROGNOSTIC NOMOGRAM
  • MOLECULAR SUBTYPES
  • RANDOMIZED-TRIALS

Cite this